Roche (OTCMKTS:RHHBY) Sees Unusually-High Trading Volume – What’s Next?

Roche Holding AG (OTCMKTS:RHHBY) shares saw an uptick in trading volume on Tuesday . 8,258,749 shares changed hands during trading, an increase of 224% from the previous session’s volume of 2,552,043 shares.The stock last traded at $51.4150 and had previously closed at $51.41.

Analyst Ratings Changes

A number of research firms have issued reports on RHHBY. TD Cowen reissued a “hold” rating on shares of Roche in a research report on Tuesday, February 10th. Wolfe Research reissued an “outperform” rating on shares of Roche in a research report on Thursday, February 26th. Argus raised shares of Roche from a “hold” rating to a “buy” rating in a research report on Monday, April 6th. The Goldman Sachs Group raised shares of Roche from a “sell” rating to a “hold” rating in a research report on Thursday, January 15th. Finally, Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target on the stock in a report on Friday, April 24th. Five investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, Roche presently has a consensus rating of “Hold” and a consensus price target of $51.50.

Roche Stock Performance

The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12. The firm’s fifty day simple moving average is $51.26 and its 200 day simple moving average is $51.15.

Institutional Investors Weigh In On Roche

Several hedge funds have recently added to or reduced their stakes in the business. Canopy Partners LLC raised its position in shares of Roche by 4.9% in the third quarter. Canopy Partners LLC now owns 7,580 shares of the company’s stock worth $317,000 after acquiring an additional 352 shares during the period. Boston Common Asset Management LLC raised its position in shares of Roche by 1.9% in the third quarter. Boston Common Asset Management LLC now owns 368,553 shares of the company’s stock worth $15,049,000 after acquiring an additional 6,720 shares during the period. Oakworth Capital Inc. acquired a new position in shares of Roche in the third quarter worth about $57,000. Sentinel Trust Co. LBA acquired a new position in shares of Roche in the third quarter worth about $878,000. Finally, Altrius Capital Management Inc raised its position in shares of Roche by 4.0% in the third quarter. Altrius Capital Management Inc now owns 198,278 shares of the company’s stock worth $8,290,000 after acquiring an additional 7,659 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.